Laryngeal papillomatosis medical therapy

Jump to navigation Jump to search

Laryngeal papillomatosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Laryngeal papillomatosis from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Laryngeal papillomatosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Laryngeal papillomatosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Laryngeal papillomatosis medical therapy

CDC on Laryngeal papillomatosis medical therapy

Laryngeal papillomatosis medical therapy in the news

Blogs on Laryngeal papillomatosis medical therapy

Directions to Hospitals Treating Laryngeal papillomatosis

Risk calculators and risk factors for Laryngeal papillomatosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Adjuvant therapies (therapies that are used in addition to surgery) have been used to treat more severe cases of laryngeal papillomatosis. Drug treatments may include antivirals such as interferon and cidofovir, which block the virus from making copies of itself, and indole-3-carbinol, a cancer-fighting compound found in cruciferous vegetables, such as broccoli and Brussels sprouts. To date, the results of these and other adjuvant therapies have been mixed or not yet fully proven. Some side effects of antivirals include dizziness, headaches, and body aches.

References

Template:WH Template:WS